NCT00004645 2005-06-24
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Office of Rare Diseases (ORD)
Phase 3 Unknown